Shi Jieliang, Liu Zhirong, Ren Xiaobin, Wang Wei, Zhang Haojie, Wang Yuanli, Liu Mingyue, Yao Qingqing, Wu Wencan
National Clinical Research Center for Ocular Diseases, National Engineering Research Center of Ophthalmology and Optometry, School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, 270 Xueyuan Xi Road, Wenzhou 325027, China.
National Clinical Research Center for Ocular Diseases, National Engineering Research Center of Ophthalmology and Optometry, School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, 270 Xueyuan Xi Road, Wenzhou 325027, China.
Int J Biol Macromol. 2025 Jan;284(Pt 1):137968. doi: 10.1016/j.ijbiomac.2024.137968. Epub 2024 Nov 22.
Critical-sized orbital bone defects can lead to significant maxillofacial deformities and even eye movement disorders. The challenges associated with these defects, including their complicated structure, inadequate blood supply, and limited availability of progenitor cells that hinder successful repair. To overcome these issues, we developed a novel approach using computer numerical control (CNC) material reduction manufacturing technology to produce a customized polyetheretherketone (PEEK) scaffold that conforms to the specific shape of orbital bone defects. Deferoxamine (DFO) was in situ encapsulated into polydopamine-hybridized zeolitic imidazolate framework-8 (pZIF8-DFO) nanoparticles, which was subsequently adhered to the sulfonated PEEK (sPEEK) scaffold through polydopamine modification. This functionalization enhanced drug loading efficiency and imparted anti-inflammatory properties to the nanoparticle system. Our in vitro findings demonstrated that the sustained release of DFO from the sPEEK/pZIF8-DFO scaffolds extended over 14 days and significantly promoted angiogenesis and progenitor cell recruitment, as evidenced by increased expression of HIF-1α, VEGF, and SDF-1α expression in human umbilical vein endothelial cells (HUVECs). Moreover, sPEEK/pZIF8-DFO scaffolds exhibited superior immunomodulation and osteogenic differentiation capabilities on Raw 264.7 cells and rabbit bone marrow mesenchymal stem cells (rBMSCs), respectively. Most notably, our in vivo rabbit orbital bone defects revealed that sPEEK/pZIF8-DFO scaffolds resulted in a greater volume of new bone formation than on sPEEK and sPEEK/pZIF8 scaffolds, with partial bone connection to the sPEEK/pZIF8-DFO scaffolds. In summary, we develop a novel PEEK scaffold that combines enhanced angiogenesis, stem cell recruitment, immunomodulation, and osteogenic differentiation, showcasing its promising potential for orbital bone reconstruction.
临界尺寸的眼眶骨缺损可导致严重的颌面畸形,甚至眼球运动障碍。与这些缺损相关的挑战包括其结构复杂、血供不足以及祖细胞可用性有限,这些都阻碍了成功修复。为了克服这些问题,我们开发了一种新颖的方法,利用计算机数控(CNC)材料减材制造技术来生产定制的聚醚醚酮(PEEK)支架,该支架符合眼眶骨缺损的特定形状。去铁胺(DFO)被原位封装到聚多巴胺杂交的沸石咪唑酯骨架-8(pZIF8-DFO)纳米颗粒中,随后通过聚多巴胺修饰将其粘附到磺化PEEK(sPEEK)支架上。这种功能化提高了药物负载效率,并赋予纳米颗粒系统抗炎特性。我们的体外研究结果表明,DFO从sPEEK/pZIF8-DFO支架中的持续释放超过14天,并显著促进血管生成和祖细胞募集,人脐静脉内皮细胞(HUVECs)中HIF-1α、VEGF和SDF-1α表达的增加证明了这一点。此外,sPEEK/pZIF8-DFO支架分别对Raw 264.7细胞和兔骨髓间充质干细胞(rBMSCs)表现出优异的免疫调节和成骨分化能力。最值得注意的是,我们对兔眼眶骨缺损的体内研究表明,sPEEK/pZIF8-DFO支架比sPEEK和sPEEK/pZIF8支架导致更大体积的新骨形成,并且与sPEEK/pZIF8-DFO支架有部分骨连接。总之,我们开发了一种新型PEEK支架,它结合了增强的血管生成、干细胞募集、免疫调节和成骨分化,展示了其在眼眶骨重建方面的广阔前景。